Dyne therapeutics ipo date
WebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. ... Dyne Therapeutics (DYN-5.97%) saw its shares slump 18.1% on Tuesday. The biotech ... WebDyne Therapeutics, Inc. Financial Information: Market Cap: $707.8mil: Revenues: $0 mil (last 12 months) Net Income $-28.2 mil (last 12 months) IPO Profile: Symbol: DYN: Exchange: NASDAQ: Shares (millions): 12.3: Price range: $19.00 - $19.00: Est. $ Volume ... Priced: Quiet Period Expiration Date: Available only to Subscribers: Lock-Up Period ...
Dyne therapeutics ipo date
Did you know?
WebApr 4, 2024 · Ticker Symbol: DYN: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $19.00: CIK Code: 0001379895: CUSIP Number: … WebDyne Therapeutics is registered under the ticker NASDAQ:DYN . Their stock opened with $19.00 in its Sep 16, 2024 IPO. Stock Symbol NASDAQ:DYN ; Valuation at IPO …
Web1 day ago · Get the latest dividend data for Dyne Therapeutics, Inc. (DYN), including dividend history, yield, key dates, growth and other metrics. ... IPOs. Recent IPOs; IPO Calendar; IPO Statistics; IPO News; IPO Screener; ETFs. ETF Screener; Compare Tool; ... Ex-Dividend Date n/a. Payout Frequency n/a. Payout Ratio n/a. WebSep 12, 2024 · Dyn Therapeutics (DYN) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement.. The …
WebSep 17, 2024 · After pricing its shares at $19 each — up from the range of $16 to $18 it had stipulated — the shares increased in value by 28% as of 2:30 p.m. on Thursday. The company is developing ... WebSep 1, 2024 · Dyne Therapeutics (DYN) aims to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The company is advancing a pipeline of drug treatment candidates for ...
WebDyne Therapeutics, Inc. Financial Information: Market Cap: $707.8mil: Revenues: $0 mil (last 12 months) Net Income $-28.2 mil (last 12 months) IPO Profile: Symbol: DYN: …
WebMar 20, 2024 · In addition to DYNE-251, Dyne is building a global DMD franchise with preclinical programs for patients with mutations amenable to skipping other exons, including 53, 45 and 44. About Dyne ... darby\u0027s olive branch msWebFunding Round search results. Post-IPO Equity - Dyne Therapeutics . Dyne Therapeutics darby\\u0027s olive branch msWebSep 17, 2024 · CureDuchenne celebrates Dyne Therapeutics’ public offering on the Nasdaq, under the ticker “DYN”. Today’s initial public offering (IPO) will elevate Dyne’s financial position and accelerate Dyne’s lead programs, which includes Duchenne muscular dystrophy. CureDuchenne values companies like Dyne that utilize fundraising tools such … darby\\u0027s of ironbridgeWebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... birth of waterWebSep 17, 2024 · Dyne Therapeutics, a preclinical biotech developing oligonucleotide therapies for rare muscular diseases, raised $233 million by offering 12.3 million shares … birth of william shakespeareWebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... IPO Date Sep 17, 2024. … darby\\u0027s olympiaWebSep 16, 2024 · WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases, … birth of wishes bnha